首页|期刊导航|肿瘤学与转化医学（英文）|Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinoma

Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinoma

Linhui Peng

肿瘤学与转化医学（英文）2025，Vol.11Issue(4)：151-155,5.

肿瘤学与转化医学（英文）2025，Vol.11Issue(4)：151-155,5.DOI:10.1097/ot9.0000000000000093

Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinoma

Linhui Peng¹

作者信息

1. Department of Hepatobiliary Surgery,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China
折叠

摘要

引用本文复制引用

Linhui Peng..Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinoma[J].肿瘤学与转化医学（英文）,2025,11(4):151-155,5.

基金项目

Supported by a grant from the Talent Exchange Service Center of National Health Commission(RCLX2315049). （RCLX2315049）

肿瘤学与转化医学（英文）

ISSN：2095-9621

访问量0

下载量0

段落导航